Reijm, E.A.( E.A. Reijm)
ezh 2 cancer breast patient expression level breast cancer tumor ezh 2 levels therapy tamoxifen signi ﬁcantly ezh 2 expression study cell numbers disease prognostic value analysis signi breast cancer res treatment bene ﬁt response value mrna expression levels prognostic mcf 7 association mcf 7 cells upregulation protein breast cancer patients outcome number ﬁcantly 1.00 histone siezh expression levels multivariate analysis experiment adjuvant sirna ici 164384 treatment range tamoxifen therapy estrogen er-positive survival factor specimen correlation prostate anti-estrogen status netherland table receptor rst-line effect proliferation zeste enhancer inhibition resistance polycomb model jansen methyltransferase carcinoma tertile tamoxifen treatment lysine sample prostate cancer control mirna -26a polymerase chain reaction cao q mirna
1 Most Recent Publications
Decreased expression of EZH2 is associated with upregulation of ER and favorable outcome to tamoxifen in advanced breast cancer
Reijm, E.A. Jansen, M.P.H.M. Ruigrok-Ritstier, K. Staveren, I.L. van Look, M.P. Meijer van Gelder, M.E. Sieuwerts, A.M. Sleijfer, S. Foekens, J.A. Berns, P.M.J.J.